The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies ...

The FDA approved several drugs throughout November for the treatment of diseases including leukemia and biliary tract cancer, in addition to a diagnostic for solid cancers. Here's a look at five ...

This analysis shows that currently available genetic evidence supported 63% (271 out of 428) of the new drugs approved in the past decade overall, with a range of 41–72% annually (Fig. 1).

They often prioritize their requests to the FDA and its EU equivalent, the European Medical Authority, EMA – they have the largest markets. But in the U.S., we do not consider cost; as a result, the ...